Purpose The aim of this study is to investigate the clinical predictors of failure of a single
dose of methotrexate (MTX) for management of ectopic pregnancy after in vitro fertilization …

Objective Methotrexate (MTX) is a minimally invasive treatment for ectopic pregnancy. As it
targets rapidly dividing cells, there is concern it may affect proliferating germinal cells in the …

Objective Women with prior ectopic pregnancy (EP) have an increased failure rate when
treated with single-dose methotrexate (MTX) for subsequent EP. We sought to determine …

Objective To evaluate the effects of methotrexate (MTX) on the future fertility of women
undergoing IVF by comparing ovarian reserve and ovarian responsiveness in the IVF cycle …

Objective: To identify risk factors for single dose methotrexate (MTX) failure among patients
treated for ectopic pregnancies. Design: Retrospective cohort. Materials and methods …

Objective: To determine variables that predict treatment failure after methotrexate (MTX)
treatment of ectopic pregnancy. Design: Retrospective cohort study. Setting: Canadian …

In a general population setting, the existence of a learning curve for treatment of ectopic
pregnancy with single-dose methotrexate has been demonstrated, because a significant …

OBJECTIVE: To evaluate whether methotrexate (MTX) compromises ovarian reserve and
future reproductive outcome in women undergoing assisted reproductive technology (ART) …

Aim Methotrexate (MTX) is an efficient treatment for ectopic pregnancy, used according to
'single‐dose'protocol. Treatment success is evaluated on days 4 and 7 after dose …

BACKGROUND: Currently, the likely success of single-dose methotrexate (MTX)(50 mg/m2)
for the treatment of ectopic pregnancy is indicated by a> 15% decrease in hCG from days 4 …